The synovium secretes synovial fluid, but is also richly innervated with nociceptors and acts as a 23 gateway between avascular joint tissues and the circulatory system. Resident fibroblast-like 24 synoviocytes' (FLS) calcium-activated potassium channels (KCa) change in activity in arthritis models 25 and this correlates with FLS activation.
Introduction

46
Rheumatoid arthritis (RA) and osteoarthritis (OA) are degenerative diseases that target articular joint structures resulting in pain, loss of function and frequent disability. Whilst RA is an 48 established inflammatory condition, the contribution of inflammatory processes to OA was less well 
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Ingenuity Pathway (IPA) Analysis (Qiagen, UK) was then used to identify the upstream regulators of 235 the global differential expression pattern. This analysis predicted the top two regulators to be TNFα 236 and IL1β (p-values 3e-17 and 6e-13 respectively), this is unsurprising since this was indeed the 237 treatment regimen.
238 Figure 3 shows the canonical calcium signally pathway (p<0.5e-7), which was enriched following 239 cytokine treatment. In addition, the rheumatoid (p<5e-13) and osteoarthritis (p<1e-9) pathways and 240 cellular movement and proliferation canonical pathways (predicted activation, p<1e-13 in both cases) 241 were also enriched following cytokine treatment (data not shown). In all cases, TNFα was determined 242 to be the top causal agent, but four ion channels were also significant causal regulators (adjusted 243 p<0.05) of the transcript-wide treatment changes; Clcn5, Trpv4, Trpv1, Kcnn4.
245
Next Generation RNA Sequencing Analysis of Ion Channel Gene Expression
246
Initial RNA-seq experiments were intended to give a transcriptome wide, unbiased, assessment of ion 247 channel changes in cytokine treated FLS. We identified 190 channel genes, including porins, connexins 248 and ion-channel isoform genes (including -to -subunits), but excluded interacting proteins, other 249 regulatory proteins and the so-called potassium tetramerization domain proteins. The top 50 genes, 250 in terms of FPKM are given for control and cytokine treated datasets in Tables S3 and S4 respectively.
252
Next Generation RNA Sequencing Ion Channel Differential Expression
253
One of the key ion channels involved with regulation of FLS is the large calcium activated potassium 254 channel (BK, Kcnmx) and it is notable that there was a reduction in expression of -subunit Kcnmb1/2 255 and appearance of Kcnmb3 after cytokine treatment. We further analysed this family transcript by 256 transcript for the 13 known (already annotated) splice variants of these channels; Kcnma1, Kcnmb1,
257
Kcnmb2, Kcnmb3, Kcnmb4 ( Figure 4C ). The most abundantly expressed of all these transcripts is 258 Kcnma1 (ENSRNOT00000077671) with rather lower expression of any of the β-subunits and no 259 I n r e v i e w detection of the one annotated Kcnmb4 variant. Following cytokine treatment expression of all of the 260 detectable Kcnma1 splice variants was higher, but there was a lower abundance of Kcnmb4.
261
In total, 20 ion channel genes, undetectable in control conditions became detectable or 'appeared' 262 after cytokine treatment (Table S5) , of which, the top expressed of these was Trpc3. Conversely, 7 ion 263 channel genes became undetectable or "disappeared" following cytokine treatment (Table S6 ).
264
Following cytokine treatment, we found an additional 15 genes to be down by -1.5 (log2) or more and 265 21 genes 1.5 (log2) greater than control (Table 1 and Table 2 respectively). We used tissue from 4 266 animals for the NGS study each animal tissue split into test and control groups; the "n" presented in 
272
Kcnn3) and other ion channel genes ( Figure 4B ). We did not have primers for all the potassium channel 273 genes identified by next generation sequencing. Three potassium genes were differentially expressed; 
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We found no overall change in the maximum amplitude of the transient ( Figure 5B ), but sustained 296 current ( Figure 5C ) density, measured at +20mV was decreased (12.5±2.3 pA/pF to 3.8±0.8pA/pF, 297 n=24,20, p<0.05). There was no change in chord conductance measured at this potential (271±45 298 pS/pF 120±20 pS/pF, n=24,20). To characterise the nature of the conductance apparently inhibited by 299 cytokine treatment we calculated the difference current for cytokine treatment (i.e., cytokine -treated 300 current; Figure 5D ). This revealed a strongly voltage-gated current with mid-point for activation 40±1. In this study we used an in vitro model of synovial cell inflammation to investigate the pathophysiology 316 of cytokine induced synovitis. We have demonstrated that IL1β and TNFα treatment of FLS cells 317 resulted in profound changes in arthritic, inflammatory and Ca 2+ regulatory pathways similar to that 318 reported in RA models. We found differential expression of several ion channels with transcriptomics 319 and our electrophysiological experiments show a reduction of whole-cell current density.
321
The pathophysiological validity of the 72hr IL1β and TNFα model 322 Treatment of joint tissue with TNF and IL1 cytokines is an established in vitro model of inflammatory 323 arthritis with tissue typically exposed to between 10ng/ml of TNF and IL1 for between 2 to 7 days.
324
In the present study, we use the lower end of the concentration range, 10ng and treat for 72hrs (De 
385
Although we found a significant increase in RNA expression of the BK α-subunit gene, Kcnma1, 
411
I n r e v i e w
Our electrophysiological experiments also demonstrated significantly more depolarised resting 412 membrane potentials in cytokine treated cells. This could result from loss of constitutive potassium or 413 chloride conductances, but equally it could result from the elevation of the nonspecific or Na + selective 414 or ion channels such as Trpc3 or Asic2 etc. (Table II) .
416
The BK pharmacological activator (NS1619) and inhibitor (paxilline) both had the expected effects 
444
is notable however, that there were significant changes in the calcium signalling pathway (Figure 3) and so it is possible that change in calcium activated potassium channel expression follows this, by way 446 of compensatory expression. The lack of apparent effect of paxilline could also be technical. For 447 example, there was considerable variability between cells and we compared population means rather 448 than pairing each cell with and without paxilline increasing the risk of a type II error.
450
Role of ion channels in pro-inflammatory cytokine production and secretion 451 Ion channels are involved not just in the response to cytokines, but can also contribute to their 
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Where negative values are equivalent to inward driving force for Ca 2+ , Vm is the membrane potential 467 and EqCa2+ is the equilibrium potential for Ca 2+ .
469
Conclusion
470
To our knowledge, this is the first report using a combined NGS and patch-clamp electrophysiological 471 approach to understanding the control of potassium channels in inflammation in joint tissues. We Afgan, E., Baker, D., Batut, B., van den Beek, M., Bouvier, D., Cech, M., Chilton, J., Clements, 497 D., Coraor, N., Gruning, B.A., Guerler, A., Hillman-Jackson, J., Hiltemann, S., Jalili, 498 V., Rasche, H., Soranzo, N., Goecks, J., Taylor, J., Nekrutenko, A. and Blankenberg, 499 D. ( 
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